MDxHealth, Predictive Biosciences deal

MDxHealth granted Predictive Biosciences exclusive, U.S. rights to undisclosed DNA methylation biomarkers for use in urine-based CertNDx Bladder Cancer Assay. MDxHealth retains exclusive, ex-U.S. righ...